TILT (CSE:TILT;OTC:SVVTF) has launched its campaign on the Investing News Network’s cannabis channel.

TILT is a vertically-integrated cannabis infrastructure and technology company providing value through a number of business models including software, infrastructure, financing and more. TILT offers state-of-the-art software solutions for each level of the supply chain, from robust greenhouse systems to retail solutions in dispensaries across North America. TILT’s vertically-integrated approach to cannabis technology has enabled to company to continue its expansion through a series of partnerships and acquisitions throughout the sector. The company’s portfolio now includes Baker Technologies, Blackbird, Briteside, Jupiter Research, Sea Hunter Therapeutics, Standard Farms and Sante Veritas Holdings.


TILT’s business model is designed to elevate the cannabis industry by improving the systems and standards used by professionals throughout the industry. The company is comprised of two main businesses, Software & Services and Consumer Devices & Packaged Goods. By focusing on these two areas, TILT has positioned itself to help businesses run more efficiently while connecting with their customers more effectively.

TILT’s company highlights include the following:

  • Vertically-integrated, B2B-focused cannabis company.
  • Seven subsidiaries are the backbone of service offerings.
  • The global cannabis market to reach US$146.4 billion by 2025.
  • Canadian cannabis market to exceed $7 billion in sales in 2019.
  • European cannabis market to reach 115.7 billion euros by 2028.
  • Unaudited pro forma 2018 annual gross revenue of US$97.3 million.
  • Unaudited pro forma January 2019 gross revenue of US$18.3 million.
  • Revenue derived from licensed software, business and consumer delivery services, vaporizing devices and cannabis products.
  • 100,000-square-feet of total retail space to come online in the near term in Massachusetts, Ohio, Illinois, Arizona and Maryland.
  • $1 billion in pending acquisitions.
  • Three core brands: One, Chroma and Slate.
  • Over 400 SKUs for medical and recreational products.
  • Management experienced in M&A and capital markets.

Click here to see the educational profile for TILT (CSE:TILT;OTC:SVVTF) and to request an investor presentation.

Chemesis International Inc. (the “Company”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is pleased to announce that all matters submitted to the shareholders of the Company at the Annual General and Special Meeting of the Company’s shareholders held on December 31, 2020 were approved.
In addition, the Company has granted, pursuant to its Equity Incentive Plan, options to purchase 1,500,000 shares of the Company exercisable for a period of 5 years at USD$0.70 per share to the directors, officers and consultants of the Company. The Company has also granted, pursuant to its Equity Incentive Plan, restricted share rights to acquire 1,500,000 shares of the Company to the directors, officers and consultants of the Company. One-half of such restricted share rights shall vest in three months from the grant date and the remaining one-half shall vest in six months from the grant date.
On Behalf of The Board of Directors
Josh Rosenberg
President
Investor Relations:
ir@chemesis.com
1 (604) 398-3378
The CSE has not reviewed, approved or disapproved the content of this press release

Source

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis extractor, announced today that the Canadian Intellectual Property Office has granted the Company a patent for the acetylation of cannabinoids. More specifically, the patent covers a process for acetylating cannabidiol (“CBD”), and subsequent refinement of CBD-O-Acetate using a proprietary extraction and distillation technique.

Keep reading... Show less

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) The Company announces that it has recently negotiated an extension to its option to purchase another 21% of Arcology for another year by an investment of $1,000,000. If the company exercises that option, it would then own 51

The Company is clarifying that in its press release of January 15th regarding the signing of a definitive agreement to acquire bit mining infrastructure, that the first phase will deliver 9,450 terahash per second, not 9,450 petahash as stated.

Keep reading... Show less

Appointment of Philip Young as CEO and director adds a seasoned executive with a track record of new device and therapeutics development, FDA/regulatory approvals, capital markets, M&A and operational success

 Lobe Sciences Ltd (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Mr. Philip J. Young as Chief Executive Officer, Corporate Secretary and a director of the Company, effective January 15, 2021. Mr. Young replaces Thomas Baird, who resigned as CEO as of the same date.

Keep reading... Show less

2020 Program Focused on Building Local Communities

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), one of the largest vertically integrated, multistate cannabis operators in the United States, announced today its employees volunteered over 5,000 service hours during a seven-month period in 2020 as part of Cresco’s “Make a Difference” initiative.

Keep reading... Show less